{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:51:36Z","timestamp":1790520696240,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010724","name":"Health Systems Research Institute","doi-asserted-by":"publisher","award":["HSRI 61-63"],"award-info":[{"award-number":["HSRI 61-63"]}],"id":[{"id":"10.13039\/501100010724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University","doi-asserted-by":"publisher","award":["2561 (CU-GR(S) 61-36-30-01)"],"award-info":[{"award-number":["2561 (CU-GR(S) 61-36-30-01)"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005627","name":"The Thrasher Research Fund","doi-asserted-by":"publisher","award":["EWAT 12348"],"award-info":[{"award-number":["EWAT 12348"]}],"id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004192","name":"National Science and Technology Development Agency","doi-asserted-by":"publisher","award":["P-15-5004"],"award-info":[{"award-number":["P-15-5004"]}],"id":[{"id":"10.13039\/501100004192","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Thrasher Fund","award":["EWAT 12348"],"award-info":[{"award-number":["EWAT 12348"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.12.065","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T13:54:48Z","timestamp":1579010088000},"page":"1643-1651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18\u00a0months of age, following monovalent hepatitis B vaccination at birth"],"prefix":"10.1016","volume":"38","author":[{"given":"Nawarat","family":"Posuwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasamon","family":"Wanlapakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sompong","family":"Vongpunsawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palittiya","family":"Sintusek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7482-799X","authenticated-orcid":false,"given":"Elke","family":"Leuridan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2337-6807","authenticated-orcid":false,"given":"Yong","family":"Poovorawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.12.065_b0005","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/jama.1989.03420220092033","article-title":"Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers","volume":"261","author":"Poovorawan","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2019.12.065_b0010","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1046\/j.1440-1746.2000.0150121356.x","article-title":"Chronic hepatitis B virus infection in Asian countries","volume":"15","author":"Merican","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2019.12.065_b0015","unstructured":"WHO. Department of Communicable Diseases Surveillance and Response. Hepatitis B, http:\/\/www.who.int\/csr\/disease\/hepatitis\/HepatitisB_whocdscsrlyo2002_2.pdf.; 2002 [accessed 4 February 2013]."},{"key":"10.1016\/j.vaccine.2019.12.065_b0020","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","article-title":"The global impact of vaccination against hepatitis B: a historical overview","volume":"26","author":"Zanetti","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.065_b0025","doi-asserted-by":"crossref","unstructured":"Posuwan N, Wanlapakorn N, Sa-Nguanmoo P, Wasitthankasem R, Vichaiwattana P, Klinfueng S, et al. The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation. PLoS One 2016;11:e0150499. http:\/\/doi: 10.1371\/journal.pone.0150499. eCollection 2016.","DOI":"10.1371\/journal.pone.0150499"},{"key":"10.1016\/j.vaccine.2019.12.065_b0030","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0264-410X(96)00226-5","article-title":"Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand","volume":"15","author":"Chunsuttiwat","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.065_b0035","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0264-410X(00)00216-4","article-title":"Impact of hepatitis B immunisation as part of the EPI","volume":"19","author":"Poovorawan","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.065_b0040","article-title":"Immunogenicity and Reactogenicity of Combined Tetravalent Diphtheria, Tetanus, Pertussis, and Hepatitis B Vaccine in Infants. Viral Hepatitis and Liver","volume":"526\u20139","author":"Poovorawan","year":"1994","journal-title":"Disease"},{"key":"10.1016\/j.vaccine.2019.12.065_b0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0264-410X(02)00461-9","article-title":"Comparative evaluation of a combined DTP-HB vaccine in the EPI in Chiangrai Province, Thailand","volume":"21","author":"Chunsuttiwat","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.065_b0050","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1016\/j.vaccine.2009.08.034","article-title":"Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination","volume":"27","author":"Tharmaphornpilas","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.065_b0055","doi-asserted-by":"crossref","unstructured":"Wanlapakorn N, Maertens K, Chaithongwongwatthana S, Srimuan D, Suratannon N, Vongpunsawad S, et al. Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women. Vaccine 2018;36:1453\u201359.http:\/\/ doi: 10.1016\/j.vaccine.2018.01.059.","DOI":"10.1016\/j.vaccine.2018.01.059"},{"key":"10.1016\/j.vaccine.2019.12.065_b0060","first-page":"ciz778","article-title":"Quantity and quality of antibodies after acellular versus whole cell pertussis vaccines in infants born to mothers who received Tdap during pregnancy: a randomised trial","author":"Wanlapakorn","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.065_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/0264-410X(90)90237-G","article-title":"Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage","volume":"8","author":"Poovorawan","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.065_b0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1086\/599331","article-title":"Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers","volume":"200","author":"Poovorawan","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.065_b0075","first-page":"496","article-title":"Experience of combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B vaccine in Thailand","volume":"28","author":"Poovorawan","year":"1997","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.vaccine.2019.12.065_b0080","first-page":"113","article-title":"Comparison study of combined DTPw-HB vaccines and separate administration of DTPw and HB vaccines in Thai children","volume":"17","author":"Poovorawan","year":"1999","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.vaccine.2019.12.065_b0085","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.vaccine.2008.01.028","article-title":"Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age","volume":"26","author":"Poovorawan","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.065_b0090","first-page":"753","article-title":"Immunogenicity and safety of quinvaxem\u00ae (diphtheria, tetanus, whole-cell pertussis, hepatitis B and haemophilus influenzae type B vaccine) give to Vietnamese infants at 2 to 4 months of age","volume":"46","author":"Huu","year":"2015","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.vaccine.2019.12.065_b0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4161\/hv.18630","volume":"8","author":"Quiambao","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.12.065_b0100","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.ijid.2010.12.004","volume":"15","author":"Kosalaraksa","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.065_b0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/21645515.2016.1225639","article-title":"Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV\/Hib in Indian infants","volume":"13","author":"Lalwani","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.12.065_b0110","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/21645515.2018.1426418","article-title":"Persistence of hepatitis B immune memory until 9\u201310 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP~T vaccination at 2, 4 and 6 months","volume":"14","author":"Kosalaraksa","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.12.065_b0115","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/INF.0000000000001601","article-title":"Pneumococcal Immune Response in Infants Whose Mothers Received Tetanus, Diphtheria and Acellular Pertussis Vaccination During Pregnancy","volume":"36","author":"Maertens","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.12.065_b0120","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1708131","article-title":"Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B","volume":"378","author":"Jourdain","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19317293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19317293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:38:20Z","timestamp":1759401500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19317293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X19317293"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18\u00a0months of age, following monovalent hepatitis B vaccination at birth","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}